Medicare Enrolled

Dr. Daniel Orlando, M.D.

Pulmonary Disease · Clearwater, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
430 MORTON PLANT ST, Clearwater, FL 33756
7274430611
In practice since 2005 (20 years)
NPI: 1043291982 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Orlando from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Orlando? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Orlando

Dr. Daniel Orlando is a pulmonary disease in Clearwater, FL, with 20 years in practice. Based on federal Medicare data, Dr. Orlando performed 2,094 Medicare services across 1,443 unique beneficiaries.

Between the years covered by Open Payments, Dr. Orlando received a total of $3,983 from 45 pharmaceutical and/or device companies across 224 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Orlando is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ Top 30% volume in FL$ $3,983 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,094
Medicare services
Top 30% in FL for pulmonary disease
1,443
Unique beneficiaries
$94
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~105 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Hospital follow-up visit, high complexity352$94$277
Critical care, first 30-74 min319$169$533
Hospital follow-up visit, moderate complexity260$63$190
Office visit, established patient (30-39 min)246$92$161
Office visit, established patient, complex (40-54 min)197$135$215
Office visit, established patient (20-29 min)108$63$109
Initial hospital admission, high complexity102$134$432
Test to examine how well the lungs exchange gases99$42$92
Test to determine lung volumes using sensors96$41$90
Test to measure expiratory airflow and volume61$20$55
Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation47$62$300
Test to measure expiratory airflow and volume changes before and after medication administration38$29$94
Test for exercise-induced lung stress35$24$68
Hospital discharge management, 30+ min35$88$280
Sleep study in sleep lab with continuous airway pressure (6 years or older)33$89$188
Initial hospital admission, moderate complexity23$99$433
Test to determine lung volumes using gas dilution or washout15$7$30
Sleep study in sleep lab (6 years or older)15$92$181
Evaluation of use of breathing device13$13$27
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$3,983
Total received (2018-2024)
Avg $569/year across 7 years
Top 43% in FL for pulmonary disease
45
Companies
224
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,983 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$928
2023
$511
2022
$234
2021
$200
2020
$299
2019
$957
2018
$853

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
GlaxoSmithKline, LLC.
$731
AstraZeneca Pharmaceuticals LP
$342
Boehringer Ingelheim Pharmaceuticals, Inc.
$320
Inari Medical, Inc.
$191
Actelion Pharmaceuticals US, Inc.
$175
Sunovion Pharmaceuticals Inc.
$173
Philips Electronics North America Corporation
$142
Insmed, Inc.
$131
Amgen Inc.
$130
Genentech USA, Inc.
$125
Harmony Biosciences LLC
$120
Bayer HealthCare Pharmaceuticals Inc.
$114
Mylan Specialty L.P.
$100
Vapotherm Inc
$84
Takeda Pharmaceuticals U.S.A., Inc.
$82
United Therapeutics Corporation
$79
Circassia Pharmaceuticals Inc
$78
PORTOLA PHARMACEUTICALS, INC.
$75
CSL Behring
$74
Regeneron Healthcare Solutions, Inc.
$68
Merck Sharp & Dohme LLC
$53
Grifols USA, LLC
$52
HARMONY BIOSCIENCES LLC
$50
Electromed, Inc.
$42
Shionogi Inc
$41
Melinta Therapeutics, Inc.
$36
Bayer Healthcare Pharmaceuticals Inc.
$32
Theravance Biopharma, Inc.
$30
Harmony Biosciences Llc
$28
Inspire Medical Systems, Inc.
$27
Merck Sharp & Dohme Corporation
$26
GENZYME CORPORATION
$25
Paratek Pharmaceuticals, Inc.
$24
Eisai Inc.
$20
Gilead Sciences, Inc.
$18
JAZZ PHARMACEUTICALS INC.
$18
Mallinckrodt LLC
$17
La Jolla Pharmaceutical Company
$16
Avadel CNS Pharmaceuticals, LLC
$16
Janssen Pharmaceuticals, Inc
$14
PFIZER INC.
$14
Allergan Inc.
$13
Teva Pharmaceuticals USA, Inc.
$13
ADVANCED RESPIRATORY, INC
$12
Nabriva Therapeutics, plc
$11
Top 3 companies account for 35.0% of total payments
Associated products mentioned in payments ›
(2809) Trilogy 100 · (6299) DreamWear · (8874) inCourage · ACTHAR · AIRSUPRA · ANDEXXA · ANORO · ASMANEX · AVYCAZ · Adempas · Arikayce · BEVESPI AEROSPHERE · BEVYXXA · BREO · CINQAIR · DUPIXENT · Dayvigo · Dymista · Esbriet · FASENRA · FLOWTRIEVER CATHETER · Fetroja · GIAPREZA · GLASSIA · INSPIRE · KEYTRUDA · Kcentra · LOKELMA · LONHALA MAGNAIR · LUMRYZ · NIOX VERO · NUCALA · NUZYRA · OFEV · OPSUMIT · OPSUMIT MACITENTAN · ORENITRAM · PREVNAR - 13 · Prolastin-C Liquid · REMODULIN · S · SMARTVEST · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · TYVASO · The Vest System Model 105 Home Care · Trilogy 100 · UPTRAVI · UTIBRON · Utibron · VAPOTHERM · VIBATIV · Vabomere · WAKIX · WINREVAIR · Wakix · XARELTO · XYREM · Xenleta · Xolair · Yupelri · ZERBAXA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $190 per 100 Medicare services performed
Looking for a pulmonary disease in Clearwater?
Compare pulmonary diseases in the Clearwater area by procedure volume, costs, and industry payment transparency.
Browse pulmonary diseases nearby

Geographic Context

Pulmonary Diseases within 10 mi
89
Per 100K population
9.3
County median income
$70,293
Nearest hospital
MORTON PLANT HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Orlando is a clinical cardiology specialist, with above-average Medicare volume (top 30% in FL), and low-engagement industry engagement, with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Orlando experienced with hospital follow-up visit, high complexity?
Based on Medicare claims data, Dr. Orlando performed 352 hospital follow-up visit, high complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Orlando receive payments from pharmaceutical companies?
Yes. Dr. Orlando received a total of $3,983 from 45 companies across 224 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Orlando's costs compare to other pulmonary diseases in Clearwater?
Dr. Orlando's average Medicare payment per service is $94. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Orlando) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →